Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...
The "Constipation Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 ...
U.S. health officials like Robert F. Kennedy Jr. tout San Patrignano, Europe's best-known rehab center, as a "beautiful model ...
Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...
Rutgers researchers William Welsh and Youyi Peng invented PW507, a new type of compound medicine for pain management.
Perinatal mothers enrolled in Michigan Medicaid between 2012 and 2021 who had opioid use disorder were more likely to have a ...
Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic pain Compelling safety and pharmacokinetic profiles in animals support IND-en ...
TipRanks on MSN
Tonix Pharma secures rights to TNX-4900 for pain management
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...
Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic ...
Amanda Eleazar, of Iowa City, was just 25 years old when she started using opioids. It was 2014, and she was a mother of four ...
Constipation Treatment Market Constipation Treatment Market Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The "Constipation ...
BOCA RATON, Fla.-- (BUSINESS WIRE)--December 15, 2025-- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results